Lima, Peru Global health specialists assert that affordability and widespread distribution are essential for the success of a durable injectable HIV prevention medicine that has demonstrated significant efficacy in human studies. The US pharmaceutical giant Gilead Sciences is pursuing regulatory approval for the medicine lenacapavir in several African nations, a crucial step towards its availability … Continue reading The Efficacy Of A Durable HIV Medication Is Contingent Upon Its Cost.